• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT Back to Search Results
Catalog Number ZIV-35-125-6.0-120-PTX
Device Problem Occlusion Within Device (1423)
Patient Problems Occlusion (1984); Surgical procedure, additional (2564)
Event Date 07/16/2014
Event Type  Injury  
Event Description
Two ziv6-35-125-6.0-120-ptx and one ziv6-35-125-7.0-120-ptx stents were placed on the right leg on (b)(6) 2012.Two ziv6-35-125-6.0-120-ptx and one ziv6-35-125-6.0-60-ptx stents were then placed on the left leg on (b)(6) 2012.On (b)(6) 2014 restenosis and worsen rutherford was confirmed in both legs.Pta was performed on both legs on the same day.The pt recovered on (b)(6) 2014.This report is in relation to one of the ziv6-35-125-6.0-120-ptx devices placed on the right leg on (b)(6) 2012.As per the above description of events received, six devices in total are involved in this incident.Five add'l separate reports will be submitted in relation to the other devices reported.(b)(4).
 
Manufacturer Narrative
Pma/510 (k) #: (b)(4).Incident requires fda mdr report based on the surgical intervention carried out due to the occurrence of restenosis in the lesion where a ptx stent was indwelling.The device involved in this complaint is as follows: ziv6-35-125-6.0-120-ptx of lot number c778568.The stent in question remains implanted in the pt and therefore is not available for eval.With the info provided, a document based investigation was carried out.No images in relation to the reported event were provided.It may be noted that restenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During pta and/or stenting).Vessel injury provokes an inflammatory response that leads (or amplifies) to the restenosis process.Restenosis of the stented artery is a known potential adverse event associated with the placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records for zilver ptx devices revealed no discrepancies which could have contributed to this complaint issue.Due to the lack of images for review and as the conditions of use cannot be replicated in a laboratory setting, it is not possible to conclusively determine the root cause for this complaint at this time.The complaint is confirmed based on customer testimony.As per the info provided following pta, the pt recovered.The risk associated with this complaint has been assessed by quality engineering and determined to be low.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Manufacturer (Section D)
COOK IRELAND LTD
limerick
EI 
Manufacturer Contact
sinead burke
3536133444
MDR Report Key4317487
MDR Text Key17571920
Report Number3001845648-2014-00292
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/15/2014
Device Catalogue NumberZIV-35-125-6.0-120-PTX
Device Lot NumberC778568
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/16/2014
Event Location Hospital
Date Manufacturer Received11/07/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/20/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-